A PROSPECTIVE, COMPARATIVE STUDY OF INTRAVENOUS IRON ISOMALTOSIDE 1000 (MONOFER®) ADMINISTERED BY INFUSIONS TO NON-ANAEMIC PATIENTS UNDERGOING ELECTIVE OR SUB-ACUTE CORONARY ARTERY BYPASS GRAFT, VALVE REPLACEMENT OR A COMBINATION THEREOF: